References
- De Leyn P, Lardinois D, Van Schil PE et al. ESTS guidelines for preoperative lymph node staging for non-small-cell lung cancer. Eur. J. Cardiothorac. Surg. 32(1), 1–8 (2007).
- Kim BT, Lee KS, Shim SS et al. Stage T1 non-small-cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT–a prospective study. Radiology 241(2), 501–509 (2006).
- Shim SS, Lee KS, Kim BT et al. Non-small-cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236(3), 1011–1019 (2005).
- Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small-cell lung cancer redundant: a prospective study. Thorax 62(8), 696–701 (2007).
- D’Addario G, Felip E; ESMO Guidelines Working Group. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 19(Suppl. 2), ii39–ii40 (2008).
- D’Addario G, Felip E; ESMO Guidelines Working Group. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 20(Suppl. 4), 68–70 (2009).
- Ettinger DS, Akerley W, Bepler G et al.; NCCN Non-Small-Cell Lung Cancer Panel Members. Non-small-cell lung cancer. J. Natl. Compr. Canc. Netw. 8(7), 740–801 (2010).
- Lee KS, Yoon JH, Kim TK, Kim JS, Chung MP, Kwon OJ. Evaluation of tracheobronchial disease with helical CT with multiplanar and 3D reconstruction: correlation with bronchoscopy. Radiographics 17(3), 555–567; discussion 568 (1997).
- Richenberg JL, Hansell DM. Image processing and spiral CT of the thorax. Br. J. Radiol. 71(847), 708–716 (1998).
- Ferretti GR, Vining DJ, Knoplioch J, Coulomb M. Tracheobronchial tree: 3D spiral CT with bronchoscopic perspective. J. Comput. Assist. Tomogr. 20(5), 777–781 (1996).
- Haponik EF, Aquino SL, Vining DJ. Virtual bronchoscopy. Clin. Chest Med. 20(1), 201–217 (1999).
- Vining DJ, Liu K, Choplin RH, Haponik EF. Virtual bronchoscopy. Relationships of virtual reality endobronchial simulations to actual bronchoscopic findings. Chest 109(2), 549–553 (1996).
- Fleiter T, Merkle EM, Aschoff AJ et al. Comparison of real-time virtual and fiberoptic bronchoscopy in patients with bronchial carcinoma: opportunities and limitations. Am. J. Roentgenol. 169(6), 1591–1595 (1997).
- Summers RM, Feng DH, Holland SM, Sneller MC, Shelhamer JH. Virtual bronchoscopy: segmentation method for real-time display. Radiology 200(3), 857–862 (1996).
- Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J. Clin. Oncol. 22(21), 4357–4368 (2004).
- Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G. PET/CT for the staging and follow-up of patients with malignancies. Eur. J. Radiol. 70(3), 382–392 (2009).
- Veit-Haibach P, Luczak C, Wanke I et al. TNM staging with FDG-PET/CT in patients with primary head and neck cancer. Eur. J. Nucl. Med. Mol. Imaging 34(12), 1953–1962 (2007).
- Antoch G, Vogt FM, Freudenberg LS et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290(24), 3199–3206 (2003).
- Gould MK, Kuschner WG, Rydzak CE et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann. Intern. Med. 139(11), 879–892 (2003).
- Antoch G, Stattaus J, Nemat AT et al. Non-small-cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229(2), 526–533 (2003).
- Kuehl H, Veit P, Rosenbaum SJ, Bockisch A, Antoch G. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J. Nucl. Med. 48(Suppl. 1), 45S–57S (2007).
- Freudenberg LS, Rosenbaum SJ, Beyer T, Bockisch A, Antoch G. PET versus PET/CT dual-modality imaging in evaluation of lung cancer. Thorac. Surg. Clin. 20(1), 25–30 (2010).
- Quon A, Napel S, Beaulieu CF, Gambhir SS. “Flying through” and “flying around” a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy. J. Nucl. Med. 47(7), 1081–1087 (2006).
- Lartizien C, Comtat C, Kinahan PE, Ferreira N, Bendriem B, Trébossen R. Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole-body PET. J. Nucl. Med. 43(9), 1268–1278 (2002).
- Herbrik M, Treffert J, Geiger B et al. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small-cell lung cancer patients. J. Nucl. Med. 52(10), 1520–1525 (2011).
- Seemann MD, Schaefer JF, Englmeier KH. Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application. Eur. Radiol. 17(3), 709–715 (2007).
- Finkelstein SE, Schrump DS, Nguyen DM, Hewitt SM, Kunst TF, Summers RM. Comparative evaluation of super high-resolution CT scan and virtual bronchoscopy for the detection of tracheobronchial malignancies. Chest 124(5), 1834–1840 (2003).
- Finkelstein SE, Summers RM, Nguyen DM, Stewart JH 4th, Tretler JA, Schrump DS. Virtual bronchoscopy for evaluation of malignant tumors of the thorax. J. Thorac. Cardiovasc. Surg. 123(5), 967–972 (2002).
- Allah MF, Hussein SR, El-Asmar AB et al. Role of virtual bronchoscopy in the evaluation of bronchial lesions. J. Comput. Assist. Tomogr. 36(1), 94–99 (2012).
- Yerushalmi D, Mullick R, Quon A et al. Simulations of virtual PET/CT 3-D bronchoscopy imaging using a physical porcine lung-heart phantom. Mol. Imaging Biol. 11(4), 275–282 (2009).
- Silvestri GA, Gould MK, Margolis ML et al.; American College of Chest Physicians. Noninvasive staging of non-small-cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132(Suppl. 3), 178S–201S (2007).
- McLoud TC, Bourgouin PM, Greenberg RW et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182(2), 319–323 (1992).
- Kanzaki R, Higashiyama M, Fujiwara A et al. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study. Lung Cancer 71(3), 333–337 (2011).
- Billé A, Pelosi E, Skanjeti A et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur. J. Cardiothorac. Surg. 36(3), 440–445 (2009).
- Cetinkaya E, Seyhan EC, Ozgul A et al. Efficacy of convex probe endobronchial ultrasound (CP-EBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small-cell lung cancer cases with mediastinal lymphadenopathy. Ann. Thorac. Cardiovasc. Surg. 17(3), 236–242 (2011).
- Cetinkaya E, Gunluoglu G, Ozgul A et al. Value of real-time endobronchial ultrasound-guided transbronchial needle aspiration. Ann. Thorac. Med. 6(2), 77–81 (2011).
- Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA; American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(Suppl 3), 202S–220S (2007).
- Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J. Thorac. Oncol. 3(6), 577–582 (2008).
- Cerfolio RJ, Bryant AS, Eloubeidi MA et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small-cell lung cancer. Ann. Thorac. Surg. 90(2), 427–434 (2010).
- Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P; Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J. Thorac. Oncol. 4(5), 568–577 (2009).